Compared to metformin administration alone, dual therapy with metformin plus TZD in PCOS patients seems to have better therapeutic performance in insulin sensitivity and HA, and may encompass an extra benefit in improving lipid metabolism [90]. This evidence concerns the gene INS and polycystic ovary syndrome.